MUSCLE LOSS ON GLP-1: HOW MUCH OF YOUR WEIGHT LOSS IS MUSCLE, AND HOW TO KEEP IT

In the large body-scan trials, muscle loss on GLP-1 medications showed up as lean mass making up about 26% of the weight lost with tirzepatide and about 40% with semaglutide. Fat made up the rest. Those numbers describe lean mass, which includes muscle along with water, organs, and other non-fat tissue, so they overstate pure muscle loss. Protein, strength training, and regular body composition checks protect it. All three are built into GLP-1 weight loss at Hartwater Wellness.
By Elaine Burris, APRN, FNP-C, Wellness Nurse Practitioner, Hartwater Wellness
Medically reviewed by Scott Bradley Burris, MD, Medical Director and board-certified anesthesiologist. Reviewed October 2026.
THE SHORT ANSWER
How much is lean mass: about 26% of the weight lost on tirzepatide (SURMOUNT-1) and about 40% on semaglutide (STEP 1), measured by DXA scans.
Is that unusual: the tirzepatide share matched the placebo group, which lost weight through diet and activity counseling alone. Any weight loss takes some lean tissue with it.
Lean mass and muscle differ: DXA lean mass counts water and organs too, so the muscle share is smaller than the headline figure.
What protects muscle: enough protein (the 2025 joint advisory suggests 80 to 120 grams a day for many adults), strength training at least three times a week, and slower, steadier loss.
How we check: an InBody 970S scan at baseline and about every 8 weeks during active treatment.
WHAT THE TRIALS MEASURED ABOUT MUSCLE LOSS ON GLP-1
Two of the main weight-loss trials scanned a subset of participants with DXA, the same X-ray method used for bone density, at the start and end of treatment. The table shows what they found and how to read it.
Three points help put the numbers in context.
The ratio held steady. In SURMOUNT-1, the share of weight lost as fat was about 75% across age groups, including adults 65 and older. Tirzepatide caused more total loss than diet counseling alone. The mix of fat and lean tissue stayed about the same.
Body composition improved. In STEP 1, lean mass fell about 10%, but fat fell about twice as fast. Lean tissue made up a larger share of each person's body at the end than at the start. For most people with obesity, that shift is the goal.
Lean mass overstates muscle. DXA counts everything that is not fat or bone as lean: muscle, water, organs, and connective tissue. Part of the measured loss is water and organ size shrinking along with body weight. Researchers writing in The Lancet Diabetes & Endocrinology in 2024 called for better muscle measurements in future trials, because lean mass alone does not show muscle strength or quality.
Muscle loss on GLP-1 therapy still matters. Muscle supports blood sugar control, strength, balance, and metabolic rate. It is also harder to rebuild after 60. The practical goal is to lose mostly fat and keep the muscle you have.
PROTEIN: HOW MUCH YOU NEED
GLP-1 medications reduce appetite. Protein is often the first thing to slip when portions shrink. In 2025, four professional societies (the American College of Lifestyle Medicine, the American Society for Nutrition, the Obesity Medicine Association, and The Obesity Society) published a joint advisory on nutrition during GLP-1 therapy. On protein, it says:
The standard adult allowance is 0.8 grams per kilogram of body weight per day, and 1.2 to 1.6 grams per kilogram has been proposed during active weight loss.
For people with obesity, basing the target on total body weight can overestimate need, so the advisory suggests about 1.5 grams per kilogram of lean (fat-free) mass when body composition is known.
A practical alternative is 80 to 120 grams a day.
The InBody scan gives us your fat-free mass at the first visit, so we can set your protein target from your own numbers. Spread it across the day, with 25 to 40 grams at each meal, since a small appetite rarely handles one large protein serving. Protein shakes, Greek yogurt, eggs, fish, and lean meats make that easier on days when food sounds unappealing. If you have kidney disease, your target needs individual review.
STRENGTH TRAINING: THE SIGNAL TO KEEP MUSCLE
Protein supplies the building material; resistance exercise tells the body to keep the muscle. The joint advisory recommends prescribing GLP-1 medications together with a structured exercise program, including strength training at least three times a week and at least 150 minutes of moderate aerobic activity.
A workable start for most patients:
Three sessions a week of 30 to 45 minutes, working the large muscle groups: legs, hips, back, chest, and shoulders.
Progressive load, adding weight or repetitions every week or two as the work gets easier.
Walking or cycling on other days for heart health and appetite rhythm.
Starting strength training before the higher doses begins makes it easier to keep up when appetite is lowest.
HOW WE TRACK MUSCLE AT HARTWATER WELLNESS
You cannot optimize what you have not measured, so every GLP-1 patient at Hartwater gets an InBody 970S body composition scan before the first dose and about every 8 weeks during active treatment. The scan reports skeletal muscle mass, fat mass, visceral fat area, and body water, by limb and trunk. Bioelectrical impedance is an estimate, and hydration affects it, so we compare scans taken under similar conditions and look at trends across several visits.
If lean mass falls faster than expected, we act on it: a higher protein target, a change in training, or a slower dose increase. Weight Loss and Metabolic Health is one of the nine health categories every Hartwater assessment ranks, and body composition is how we judge whether the plan is working. The patient experience page shows where the scan fits in your first visit.
WHERE EVOLVEX FITS
Some patients also ask about EvolveX muscle toning at Hartwater Aesthetics, in Suite 110 of the same building. EvolveX Tone uses electrical muscle stimulation to make targeted muscles (abdomen, arms, buttocks, thighs) contract repeatedly during a session of about 45 minutes to an hour. It is sold as a six-session package per area, $2,500 for the most common areas.
EvolveX is an add-on to strength training and protein. No published trial has measured whether muscle stimulation preserves lean mass in people taking GLP-1 medications, so we present it as a targeted add-on for patients who want more definition in specific areas, coordinated with your GLP-1 plan.
FREQUENTLY ASKED QUESTIONS
How much muscle do you lose on Ozempic or Wegovy?
In the STEP 1 body-scan substudy of semaglutide 2.4 mg (the Wegovy dose), lean mass fell about 10% over 68 weeks and made up about 40% of the weight lost. Lean mass includes water and organs, so the true muscle share is lower. Ozempic is the same medicine at lower doses, approved for type 2 diabetes.
Does tirzepatide cause less muscle loss than semaglutide?
In the separate DXA substudies, lean mass made up about 26% of the weight lost with tirzepatide and about 40% with semaglutide. The trials used different people, durations, and methods, and no head-to-head body composition trial has been published, so the comparison is suggestive only.
How much protein should I eat on a GLP-1?
The 2025 joint advisory suggests 80 to 120 grams a day as a practical range, or about 1.5 grams per kilogram of fat-free mass when body composition is known. We set your target from your InBody scan and adjust it at follow-up visits.
Can I keep muscle on a GLP-1 without going to the gym?
Strength training is the best-supported tool, and it can be done at home with resistance bands, dumbbells, or body weight. Walking alone helps your heart and appetite but does little to keep muscle. Aim for at least three strength sessions a week.
SCHEDULE A CONSULTATION
If you are starting a GLP-1 or already on one and want to know how much of your loss is fat, a consultation with a body composition scan is the place to start. Hartwater Wellness is a physician-led practice at 7200 West University Drive, Suite 170, in McKinney, serving Frisco, Allen, Prosper, Plano, Celina, and Collin County. Schedule online or call (469) 678-8748.
SOURCES
Wilding JPH et al., Once-Weekly Semaglutide in Adults with Overweight or Obesity (STEP 1, including the DXA substudy), New England Journal of Medicine 2021;384:989-1002: https://doi.org/10.1056/NEJMoa2032183
Look M et al., Body composition changes during weight reduction with tirzepatide in the SURMOUNT-1 study of adults with obesity or overweight, Diabetes, Obesity and Metabolism 2025;27(5):2720-2729: https://doi.org/10.1111/dom.16275
Neeland IJ, Linge J, Birkenfeld AL, Changes in lean body mass with glucagon-like peptide-1-based therapies and mitigation strategies, Diabetes, Obesity and Metabolism 2024: https://doi.org/10.1111/dom.15728
Prado CM et al., Muscle matters: the effects of medically induced weight loss on skeletal muscle, The Lancet Diabetes & Endocrinology 2024: https://doi.org/10.1016/S2213-8587(24)00272-9
Mozaffarian D et al., Nutritional Priorities to Support GLP-1 Therapy for Obesity: A Joint Advisory From the American College of Lifestyle Medicine, the American Society for Nutrition, the Obesity Medicine Association, and The Obesity Society, American Journal of Lifestyle Medicine 2025 (also American Journal of Clinical Nutrition 2025): https://doi.org/10.1177/15598276251344827
Hartwater Aesthetics, EvolveX muscle toning (sessions, package price, treatment areas), checked 2026-10-28: https://www.hartwateraesthetics.com/muscle-toning
.png)